Publisher of the most cited open-access journals in their fields.
At Frontiers in Cardiovascular Medicine we believe it is worth being curious to foresee and explore beyond the current frontiers. In other words, we would like, through the articles published by our community journal, to anticipate the future of cardiovascular medicine, and thus better prevent cardiovascular disorders and improve therapeutic options and outcomes of our patients.
Frontiers? Which frontiers? Where exactly are the frontiers of cardiovascular medicine? And who should be defining these frontiers?
At Frontiers in Cardiovascular Medicine we believe it is worth being curious to foresee and explore beyond the current frontiers. In other words, we would like, through the articles published by our community journal Frontiers in Cardiovascular Medicine, to anticipate the future of cardiovascular medicine, and thus better prevent cardiovascular disorders and improve therapeutic options and outcomes of our patients.
Frontiers in Cardiovascular Medicine has the following missions, intended to guide the cardiovascular community of researchers, authors, editors, reviewers, readers and patients:
Exploring the frontiers and pushing the boundaries of current knowledge in cardiovascular medicine face some complex issues. For example, while therapeutic possibilities continue to expand due to scientific and technological developments their clinical application may be limited by ethical, political or economic factors.
At Frontiers in Cardiovascular Medicine we aim to explore these complex questions and overcome such multifaceted challenges. We seek to examine the potentials but also imperfections of any new development in all areas of cardiovascular medicine. Frontiers in Cardiovascular Medicine therefore covers all aspects of cardiovascular health, prevention, treatment and care, with a particular emphasis on studies that challenge the status quo of treatments and practices in cardiovascular care through the following specialty sections:
General Cardiovascular Medicine
Cardiovascular Epidemiology, Quality and Outcomes
Coronary Vascular System
Heart Failure and Transplantation
Cardiovascular Biologics and Regenerative Medicine
Cardiovascular Genetics and Systems Medicine
Thrombosis and Vascular Medicine
Over the coming months we will launch many more sections to fulfill our mission of pushing the frontiers of cardiovascular medicine.
In addition to our specialty sections, we also welcome Frontiers Research Topics, whereby you and your colleagues can join forces to publish thematic article collections that further explore and push the boundaries of specific fields of cardiovascular medicine.
Frontiers in Cardiovascular Medicine does not simply report your experience. Through our open access policy and sophisticated web platform combined with a creative commons license, Frontiers in Cardiovascular Medicine transforms your studies into new sources of inspiration for the cardiovascular medicine community to further research and clinical practice. And it is you, the authors and readers, who are insufflating this dynamic. We, the editors of Frontiers in Cardiovascular Medicine manage the platform that allows you to share and discuss ideas, opinions, data and experiences as a community.
Frontiers in Cardiovascular Medicine's editorial board consists of a large team of specialised and qualified researchers, clinicians and physician scientists, whose role is to engage you in open discussions and help you improve the way in which your experience are shared with the cardiovascular medicine community. Importantly, we encourage all relevant and active researchers/practitioners to take part in the editorial process at Frontiers in Cardiovascular Medicine to help support our community-driven approach to medical publishing.
At Frontiers in Cardiovascular Medicine our editors adopt a collaborative attitude towards the communication of scientific research results and clinical experience. Our editors gauge the scientific accuracy of the work and seek, through direct dialogue with you via our interactive review forum, to understand your study and work with you to improve the way in which the results are communicated to everyone involved, including our patients.
To recognize the vital contribution of our reviewers and editors, all names are acknowledged in the final published paper. This feature of all Frontiers journals provides maximal transparency regarding manuscript assessment and also another layer of endorsement from specific experts in cardiovascular medicine, rather than the journal name alone.
Through Frontiers’ superior web platform and open access publishing model, articles published in Frontiers in Cardiovascular Medicine enjoy extensive views and downloads. Frontiers’ article-level metrics offer you real-time feedback on the attention your work has received and important information such as the demographics and geographical distribution of your audience.
Importantly, through Frontiers Research Topics, whereby articles on a topic are published in online collections, you can achieve even higher exposure and more recognition from the community through the interconnectivity of our content.
Frontiers in Cardiovascular Medicine upholds the highest ethical standards in research and medical publishing. By submitting your article to Frontiers in Cardiovascular Medicine you confirm that your work has been performed in accordance with the guidelines outlined in the Declaration of Helsinki and complies with national guidelines as well as the integrity rules of your institution.
For manuscripts reporting studies involving human subjects, authors must clearly identify the full name of the ethics committee that approved the study and confirm that study subjects have granted their written informed consent. Studies involving research animals must uphold the same high ethical standards, and authors must identify the full name of the ethics committee that approved the work.
In accordance with the ICMEJ's Clinical Trial Registration Statement, all clinical trials must be registered in a public trials registry at or before the onset of participant enrollment. To meet the requirements of the ICMJE, clinical trials can be registered with any Primary Registry in the WHO Registry Network or an ICMJE-approved registry. The information on the clinical trial registration (Unique Identifier and URL) must be included in the abstract.
Importantly at Frontiers in Cardiovascular Medicine, we believe that it is everyone’s responsibility to ensure medical research and publishing are conducted ethically. To facilitate the process we provide many checks throughout the submission and peer review process: you are asked to make the relevant and necessary declarations upon manuscript submission, including any potential conflicts of interest and authorship statements. Editors and editorial office staff also check that the necessary information pertaining to ethical research and competing interest are included in the manuscripts. Furthermore, our editors are fully informed of what constitutes a potential conflict of interest and are requested to disclose this information prior to accepting editing assignments.
You are highly encouraged to take a proactive role in contributing to ethical research and publishing by:
• Conducting your research and clinical studies in a manner that conforms with national guidelines and the Declaration of Helsinki;
• Registering your clinical trial with the above named registries where necessary;
• Adhering to the ICMJE’s authorship criteria;
• Requesting only handling editors who do not have a conflict of interest with you, both real and perceived;
• Declaring any financial or commercial competing interests.
We look forward to your active participation in Frontiers in Cardiovascular Medicine: together, we will push the boundaries of cardiovascular medicine for better health, prevention, treatment and care of our patients.
Frontiers in Cardovasculare Medicine is member of the Committee on Publication Ethics.
Short Name: Front. Cardiovasc. Med.
Electronic ISSN: 2297-055X
Indexed in: PubMed, PubMed Central, Google Scholar, DOAJ
PMCID: all published articles receive a PMCID
Frontiers in Cardiovascular Medicine is composed of the following Specialty Sections:
The specialty sections of Frontiers in Cardiovascular Medicine welcome submission of the following article types: Book Review, Case Report, Clinical Study Protocol, Clinical Trial, Correction, Data Report, Editorial, General Commentary, Hypothesis & Theory, Methods, Mini Review, Opinion, Original Research, Perspective, Review, Technology Report, Curriculum, Instruction, and Pedagogy, Specialty Grand Challenge, Addendum, Community Case Study, Erratum, Field Grand Challenge, Focused Review and Frontiers Commentary.
When submitting a manuscript to Frontiers in Cardiovascular Medicine, authors must submit the material directly to one of the specialty sections. Manuscripts are peer-reviewed by the Associate and Review Editors of the respective specialty section.
Articles published in the specialty sections above will benefit from the Frontiers impact and tiering system after online publication. Authors of published original research with the highest impact, as judged democratically by the readers, will be invited by the Chief Editor to write a Frontiers Focused Review - a tier-climbing article. This is referred to as "democratic tiering". The author selection is based on article impact analytics of original research published in the Frontiers specialty journals and sections. Focused Reviews are centered on the original discovery, place it into a broader context, and aim to address the wider community across all of Cardiovascular Medicine.